Scott Watson

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.

Exane SA (United Kingdom) is the UK-based securities brokerage division of Exane SA in France, which is owned by BNP Paribas SA (EPA: BNP). Headquartered in London, the firm was founded in 2019 and provides institutional investors with a range of services, such as research, sale and execution on European equities.